Published in Mol Pharmacol on January 26, 2009
Evidence against dopamine D1/D2 receptor heteromers. Mol Psychiatry (2015) 1.56
Olfactory bulb short axon cell release of GABA and dopamine produces a temporally biphasic inhibition-excitation response in external tufted cells. J Neurosci (2013) 1.29
Dopamine receptors in a songbird brain. J Comp Neurol (2010) 1.20
The dopamine d1-d2 receptor heteromer in striatal medium spiny neurons: evidence for a third distinct neuronal pathway in Basal Ganglia. Front Neuroanat (2011) 1.19
Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation. Biochim Biophys Acta (2010) 1.13
Heteromerization of dopamine D2 receptors with dopamine D1 or D5 receptors generates intracellular calcium signaling by different mechanisms. Curr Opin Pharmacol (2009) 1.11
Adenosine-cannabinoid receptor interactions. Implications for striatal function. Br J Pharmacol (2010) 1.07
Dopamine D1-D2 receptor heteromer signaling pathway in the brain: emerging physiological relevance. Mol Brain (2011) 1.06
Dopamine receptor expression and distribution dynamically change in the rat nucleus accumbens after withdrawal from cocaine self-administration. Neuroscience (2010) 1.06
Pharmacology of signaling induced by dopamine D(1)-like receptor activation. Pharmacol Ther (2010) 1.02
Identification of Novel G Protein-Coupled Receptor 143 Ligands as Pharmacologic Tools for Investigating X-Linked Ocular Albinism. Invest Ophthalmol Vis Sci (2017) 0.97
Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance. Neuropsychopharmacology (2013) 0.96
Reversal of dopamine inhibition of dopaminergic neurons of the ventral tegmental area is mediated by protein kinase C. Neuropsychopharmacology (2011) 0.94
Dopamine receptor homooligomers and heterooligomers in schizophrenia. CNS Neurosci Ther (2010) 0.89
Dopamine receptors - IUPHAR Review 13. Br J Pharmacol (2015) 0.87
D1 dopamine receptor signaling is modulated by the R7 RGS protein EAT-16 and the R7 binding protein RSBP-1 in Caenoerhabditis elegans motor neurons. PLoS One (2012) 0.86
An extended reinforcement learning model of basal ganglia to understand the contributions of serotonin and dopamine in risk-based decision making, reward prediction, and punishment learning. Front Comput Neurosci (2014) 0.85
A physiological role for the dopamine D5 receptor as a regulator of BDNF and Akt signalling in rodent prefrontal cortex. Int J Neuropsychopharmacol (2012) 0.84
Reduced striatal dopamine D1-D2 receptor heteromer expression and behavioural subsensitivity in juvenile rats. Neuroscience (2012) 0.83
Dopaminergic Regulation of Innate Immunity: a Review. J Neuroimmune Pharmacol (2017) 0.81
D5 dopamine receptor carboxyl tail involved in D5-D2 heteromer formation. Biochem Biophys Res Commun (2013) 0.81
Dopamine and full-field illumination activate D1 and D2-D5-type receptors in adult rat retinal ganglion cells. J Comp Neurol (2012) 0.80
Functional characterization of G-protein-coupled receptors: a bioinformatics approach. Neuroscience (2014) 0.80
Intranasal delivery of a peptide with antidepressant-like effect. Neuropsychopharmacology (2014) 0.78
Chronic cocaine disrupts mesocortical learning mechanisms. Brain Res (2015) 0.78
Biological Significance of GPCR Heteromerization in the Neuro-Endocrine System. Front Endocrinol (Lausanne) (2011) 0.78
The effect of modafinil on the rat dopamine transporter and dopamine receptors D1-D3 paralleling cognitive enhancement in the radial arm maze. Front Behav Neurosci (2015) 0.78
Targeting Dopamine in Acute Traumatic Brain Injury. Open Drug Discov J (2010) 0.78
Neuroprotective potential of Bacopa monnieri and Bacoside A against dopamine receptor dysfunction in the cerebral cortex of neonatal hypoglycaemic rats. Cell Mol Neurobiol (2013) 0.78
Suppression of Gq Function Using Intra-Pipette Delivery of shRNA during Extracellular Recording in the Ventral Tegmental Area. Front Cell Neurosci (2013) 0.77
Dopamine modulation of transient receptor potential vanilloid type 1 (TRPV1) receptor in dorsal root ganglia neurons. J Physiol (2016) 0.76
Activation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditions. BMC Musculoskelet Disord (2011) 0.76
Enhanced brain-derived neurotrophic factor signaling in the nucleus accumbens of juvenile rats. Dev Neurosci (2013) 0.76
Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and Disease. Front Cell Neurosci (2017) 0.75
Methamphetamine compromises gap junctional communication in astrocytes and neurons. J Neurochem (2016) 0.75
The TRP ion channel family. Nat Rev Neurosci (2001) 5.15
Mechanisms of capacitative calcium entry. J Cell Sci (2001) 3.50
Closed state of both binding domains of homodimeric mGlu receptors is required for full activity. Nat Struct Mol Biol (2004) 2.58
Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. J Mol Biol (2003) 2.57
D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci U S A (2006) 2.48
Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem (2004) 2.32
Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons. Nat Neurosci (2000) 1.88
Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons. J Neurosci (2003) 1.66
Dopamine receptor subtypes colocalize in rat striatonigral neurons. Proc Natl Acad Sci U S A (1992) 1.62
Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain. J Neurosci (1995) 1.61
Inhibition by dopamine of (Na(+)+K+)ATPase activity in neostriatal neurons through D1 and D2 dopamine receptor synergism. Nature (1990) 1.48
Galpha12- and Galpha13-protein subunit linkage of D5 dopamine receptors in the nephron. Hypertension (2003) 1.17
D5 (not D1) dopamine receptors potentiate burst-firing in neurons of the subthalamic nucleus by modulating an L-type calcium conductance. J Neurosci (2003) 1.06
Microdomains for dopamine volume neurotransmission in primate prefrontal cortex. J Neurosci (2004) 1.05
Feedback activation of phospholipase C via intracellular mobilization and store-operated influx of Ca2+ in insulin-secreting beta-cells. J Cell Sci (2005) 1.03
Novel insights in dopamine receptor physiology. Eur J Endocrinol (2007) 0.99
Involvement of extracellular Ca2+ influx through voltage-independent Ca2+ channels in endothelin-1 function. Cell Signal (2005) 0.95
Multiple coupling of human D5 dopamine receptors to guanine nucleotide binding proteins Gs and Gz. J Neurochem (1998) 0.94
Immunoblot and immunohistochemical comparison of murine monoclonal antibodies specific for the rat D1a and D1b dopamine receptor subtypes. J Neuroimmunol (1999) 0.94
Structures of dopamine receptors. J Neurochem (1993) 0.94
Behavioral synergism between D(1) and D(2) dopamine receptors in mice does not depend on gap junctions. Synapse (2007) 0.90
Effects of individual and concurrent stimulation of striatal D1 and D2 dopamine receptors on electrophysiological and behavioral output from rat basal ganglia. J Pharmacol Exp Ther (2002) 0.89
Dopamine D5 receptor agonist high affinity and constitutive activity profile conferred by carboxyl-terminal tail sequence. J Biol Chem (2000) 0.89
Ethological resolution of behavioural topography and D1-like versus D2-like agonist responses in congenic D5 dopamine receptor mutants: identification of D5:D2-like interactions. Synapse (2005) 0.88
Co-stimulation of D(1)/D(5) and D(2) dopamine receptors leads to an increase in c-fos messenger RNA in cholinergic interneurons and a redistribution of c-fos messenger RNA in striatal projection neurons. Neuroscience (2000) 0.86
Dopamine induces a biphasic modulation of hypothalamic ANF neurons: a ligand concentration-dependent effect involving D5 and D2 receptor interaction. Mol Psychiatry (2000) 0.85
Phospholipase C-delta and related molecules. Biochem Soc Trans (1999) 0.78
G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat Rev Drug Discov (2002) 3.19
D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci U S A (2006) 2.48
Building a new conceptual framework for receptor heteromers. Nat Chem Biol (2009) 2.41
Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem (2004) 2.32
Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth. Proc Natl Acad Sci U S A (2009) 1.67
Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis. Proc Natl Acad Sci U S A (2005) 1.67
Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors. J Biol Chem (2003) 1.57
Characterization of a family of endogenous neuropeptide ligands for the G protein-coupled receptors GPR7 and GPR8. Proc Natl Acad Sci U S A (2003) 1.33
The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: increased high affinity state following amphetamine and in schizophrenia. J Biol Chem (2010) 1.33
A role for the distal carboxyl tails in generating the novel pharmacology and G protein activation profile of mu and delta opioid receptor hetero-oligomers. J Biol Chem (2005) 1.20
The dopamine d1-d2 receptor heteromer in striatal medium spiny neurons: evidence for a third distinct neuronal pathway in Basal Ganglia. Front Neuroanat (2011) 1.19
Modification of the terminal residue of apelin-13 antagonizes its hypotensive action. Endocrinology (2004) 1.17
Neuronal Gq/11-coupled dopamine receptors: an uncharted role for dopamine. Trends Pharmacol Sci (2007) 1.16
D1 and D2 dopamine receptors form heterooligomers and cointernalize after selective activation of either receptor. Mol Pharmacol (2005) 1.16
Trafficking of preassembled opioid mu-delta heterooligomer-Gz signaling complexes to the plasma membrane: coregulation by agonists. Biochemistry (2007) 1.16
Oligomerization of opioid receptors: generation of novel signaling units. Curr Opin Pharmacol (2002) 1.14
FoxO6 regulates memory consolidation and synaptic function. Genes Dev (2012) 1.14
D2 dopamine receptor homodimerization is mediated by multiple sites of interaction, including an intermolecular interaction involving transmembrane domain 4. Biochemistry (2003) 1.13
A novel dopamine receptor signaling unit in brain: heterooligomers of D1 and D2 dopamine receptors. ScientificWorldJournal (2007) 1.13
Unravelling the roles of the apelin system: prospective therapeutic applications in heart failure and obesity. Trends Pharmacol Sci (2006) 1.13
The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study. PLoS One (2009) 1.11
Heteromerization of dopamine D2 receptors with dopamine D1 or D5 receptors generates intracellular calcium signaling by different mechanisms. Curr Opin Pharmacol (2009) 1.11
Insights into the role of dopamine receptor systems in learning and memory. Rev Neurosci (2007) 1.10
Deletion of dopamine D1 and D3 receptors differentially affects spontaneous behaviour and cocaine-induced locomotor activity, reward and CREB phosphorylation. Eur J Neurosci (2005) 1.09
GPCR-OKB: the G Protein Coupled Receptor Oligomer Knowledge Base. Bioinformatics (2010) 1.09
Novel human G-protein-coupled receptors. Biochem Biophys Res Commun (2003) 1.08
Increasing CREB function in the CA1 region of dorsal hippocampus rescues the spatial memory deficits in a mouse model of Alzheimer's disease. Neuropsychopharmacology (2011) 1.08
Regulation of D1 dopamine receptor trafficking and signaling by caveolin-1. Mol Pharmacol (2007) 1.07
Dopamine D1-D2 receptor heteromer signaling pathway in the brain: emerging physiological relevance. Mol Brain (2011) 1.06
Homo- and hetero-oligomerization of G protein-coupled receptors. Life Sci (2003) 1.05
Requirements and ontology for a G protein-coupled receptor oligomerization knowledge base. BMC Bioinformatics (2007) 1.04
The antipsychotic potential of l-stepholidine--a naturally occurring dopamine receptor D1 agonist and D2 antagonist. Psychopharmacology (Berl) (2008) 1.00
Dopamine receptor oligomerization visualized in living cells. J Biol Chem (2005) 1.00
Design and synthesis of photoaffinity-labeling ligands of the L-prolyl-L-leucylglycinamide binding site involved in the allosteric modulation of the dopamine receptor. J Med Chem (2006) 0.97
Distinct residues in the carboxyl tail mediate agonist-induced desensitization and internalization of the human dopamine D1 receptor. J Biol Chem (2001) 0.97
Attenuation of sucrose reinforcement in dopamine D1 receptor deficient mice. Eur J Neurosci (2003) 0.97
A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors. Clin Endocrinol (Oxf) (2008) 0.96
Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance. Neuropsychopharmacology (2013) 0.96
The fate of the internalized apelin receptor is determined by different isoforms of apelin mediating differential interaction with beta-arrestin. Biochem Biophys Res Commun (2010) 0.96
Minireview: Diversity and complexity of signaling through peptidergic G protein-coupled receptors. Endocrinology (2004) 0.94
Desensitization of the dopamine D1 and D2 receptor hetero-oligomer mediated calcium signal by agonist occupancy of either receptor. Mol Pharmacol (2007) 0.94
Phasic D1 and tonic D2 dopamine receptor signaling double dissociate the motivational effects of acute nicotine and chronic nicotine withdrawal. Proc Natl Acad Sci U S A (2012) 0.94
Dopamine D1-D2 receptor Heteromer-mediated calcium release is desensitized by D1 receptor occupancy with or without signal activation: dual functional regulation by G protein-coupled receptor kinase 2. J Biol Chem (2010) 0.93
Separation and reformation of cell surface dopamine receptor oligomers visualized in cells. Eur J Pharmacol (2011) 0.92
Dopamine D1-D2 receptor heteromer in dual phenotype GABA/glutamate-coexpressing striatal medium spiny neurons: regulation of BDNF, GAD67 and VGLUT1/2. PLoS One (2012) 0.92
Inactivation of Kv3.3 potassium channels in heterologous expression systems. J Biol Chem (2003) 0.92
Agonist-induced cell surface trafficking of an intracellularly sequestered D1 dopamine receptor homo-oligomer. Mol Pharmacol (2006) 0.91
A usability study of a computerized decision aid to help patients with, early stage papillary thyroid carcinoma in, decision-making on adjuvant radioactive iodine treatment. Patient Educ Couns (2010) 0.91
Disruption of the mu-delta opioid receptor heteromer. Biochem Biophys Res Commun (2012) 0.91
Dopamine receptor homooligomers and heterooligomers in schizophrenia. CNS Neurosci Ther (2010) 0.89
Two amino acids in each of D1 and D2 dopamine receptor cytoplasmic regions are involved in D1-D2 heteromer formation. Biochem Biophys Res Commun (2011) 0.89
Mu-opioid receptor heterooligomer formation with the dopamine D1 receptor as directly visualized in living cells. Eur J Pharmacol (2007) 0.88
Advancing drug discovery for schizophrenia. Ann N Y Acad Sci (2011) 0.86
Using ligand-induced conformational change to screen for compounds targeting G-protein-coupled receptors. J Biomol Screen (2007) 0.85